Evado Opens US Office
Evado, a clinical software provider, recently announced the opening of a new office in San Francisco, California, USA. The newly appointed Director of Business Development, Ms Maria Chiam will operate from Evado's US office.Evado CEO, Ms Jennie Anderson said that the US office gives Evado a permanent footprint into the US market. "We have already established sales channels in Taiwan, China and Singapore, but this is our first international office and we believe being in the US will be more convenient for our US customers," she said.
"Ms Chiam has successfully launched corporate brands and products in both the USA and Asia Pacific and she believes that Evado will help US customers who are facing a challenging economic and regulatory environment to quickly and economically set up trials and studies."
The US office is the first of many important international initiatives for Evado in 2012. "The opening of our new office is an important step in realizing our goals and builds on our future international potential," said Ms Anderson.
With increasing demand for user friendly, economical and efficient clinical software in the US market, Evado decided to establish operations in San Francisco in 2012. The San Francisco office will offer the full range of Evado clinical software modules, including pre-clinical, clinical electronic data capture, clinical trial management systems, patient and disease registry, post market surveillance, integration server and imaging repository.
About Evado
Evado is an Australia-based IT company that has developed web-based form technologies that are specifically designed to help organizations manage clinical trial and studies. Evado management comprises a group of highly skilled engineers, scientists and health professionals with over 25 years experience health and life science sector. The company operates in Australia, the Asia Pacific and the USA. Evado's customers include: research institutes, universities, small and large drug developers and medical device manufacturers all of whom use Evado for pre-clinical through to late stage trials and post market studies. For the past 5 years Evado has been successfully used in GCP and FDA compliant clinical trials and studies.
The Evado approach is to generate dynamic online forms that look similar to a paper case report form (CRF). This makes the form data collection process very intuitive and easy to use. Evado can be used for investigator-led studies, clinical trials and clinical registries. The Evado clinical module can be used for trial data collection and Evado's management module for trial management and reporting. The Evado technology is lightweight and very fast. Evado has been successfully audited against the requirements of the TGA, FDA 21CFR and ICH GCP.
The Evado clinical software solution provides a cost effective, compliant solution for the data collection and management of clinical trials.
Evado enables clinical researchers to configure trial software in just days or weeks rather than months. Customer studies have shown that Evado trials can be setup ten times faster than some of our major competition.
The Evado cloud solution provides significant benefits in cost, setup time, flexibility and visibility to both research and commercial clients and clients can develop their own forms or outsource their development to Evado depending on their timelines and budgets.
SOURCE: Evado Clinical Software